Institut Pasteur (IP) is a non-profit foundation dedicated to the prevention and treatment of diseases through biomedical research, education, and public health activities. For over a century, IP has been at the forefront of the battle against infectious diseases. Organised in 10 departments IP is recognised as a leader in infectious diseases research, and ranked as a top-level institution for publication impact in the field of microbiology. Through its International network of 32 Pasteur Institutes in 27 countries IP contributes to a better detection and control of pathogens of major concern for Human and Animal Health. A high-level technology park, composed of 10 state-of-the-art technological platforms, offers cutting-edge equipment and know-how. The IP’s Teaching Centre offers a high-quality training program to young French and foreign researchers through a unique combination of high-quality theoretical, analytical and technical courses and lectures. Within the Department of Virology, the unit of “Molecular Genetics of RNA Viruses” is headed by Prof. Sylvie van der Werf. The unit is the coordinating laboratory of the French National Reference Centre for influenza and hosts the WHO National Influenza Centre (Northern-France) and WHO H5 reference laboratory. The unit currently coordinates the FP7 project PREDEMICS (278433) and participates in several other European FP7 projects (EMPERIE, FLU-PHARM, FIBEBIOTICS) as well as in the FLURISK project funded by EFSA.
02 March 2015
Bookmark the permalink.
- No events
- WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globallyWHO and UNICEF today issued new ten-step guidance to increase support for breastfeeding in health facilities that provide maternity and newborn services. Breastfeeding all babies for the first 2 years would save the lives of more than 820 000 children under age 5 annually. The Ten Steps to Successful Breastfeeding underpin the Baby-friendly Hospital Initiative, […]
- WHO concerned about suspected chemical attacks in SyriaWHO is deeply alarmed by reports of the suspected use of toxic chemicals in Douma city, East Ghouta. According to reports from Health Cluster partners, during the shelling of Douma on Saturday, an estimated 500 patients presented to health facilities exhibiting signs and symptoms consistent with exposure to toxic chemicals. In particular, there were signs […]
- Nearly one billion people in Africa to be protected against yellow fever by 2026Nearly one billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from WHO, Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners. The commitment is part of the Eliminate Yellow fever Epidemics (EYE) in Africa strategy, which was launched by Dr Tedros Adhanom Ghebreyesus, […]
- WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally